Author:
Riehle Christian,Sieweke Jan-Thorben,Udesen Nanna Louise Junker,Helgestad Ole K.L.,Froese Natali,Ravn Hanne Berg,Lichtinghagen Ralf,Møller Jacob E.,Bauersachs Johann,Schäfer Andreas
Funder
Abiomed
Deutsche Forschungsgemeinschaft
Novo Nordisk Fonden
Reference15 articles.
1. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective;Goldberg;Circulation.,2009
2. Protein-based cardiogenic shock patient classifier;Rueda;Eur. Heart J.,2019
3. Molecular signature of cardiogenic shock;Iborra-Egea;Eur. Heart J.,2020
4. An outlook on biomarkers in cardiogenic shock;Iborra-Egea;Curr. Opin. Crit. Care,2020
5. The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction;Ceglarek;Eur. Heart J.,2021